Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Posaconazole for the Prevention of COVID-19 Associated Pulmonary Aspergillosis in Critically-Ill Patients: A European Multicenter Case-Control Study

NCT05065658 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT05065658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05065658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Posaconazole for the Prevention of COVID-19 Associated Pulmonary Aspergillosis in Critically-Ill Patients: A European Multicenter Case-Control Study
Lead sponsor
Medical University of Graz
Phase
Observational
Overall status
Completed
Start date
March 1, 2020
Completion date
August 23, 2023
Enrollment
249 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

aspergillosis, covid-19 respiratory infection